Abstract:Background Acute lung injury (ALI) and its most severe form acute respiratory distress syndrome (ARDS) have been the leading cause of morbidity and mortality in intensive care units (ICU). Currently, there is no effective pharmacological treatment for acute lung injury. Curcumin, extracted from turmeric, exhibits broad anti-inflammatory properties through down-regulating inflammatory cytokines. However, the instability of curcumin limits its clinical application. Methods A series of new curcumin analogs were synthesized and screened for their inhibitory effects on the production of TNF-α and IL-6 in mouse peritoneal macrophages by ELISA. The evaluation of stability and mechanism of active compounds was determined using UV-assay and Western Blot, respectively. In vivo , SD rats were pretreatment with c26 for seven days and then intratracheally injected with LPS to induce ALI. Pulmonary edema, protein concentration in BALF, injury of lung tissue, inflammatory cytokines in serum and BALF, inflammatory cell infiltration, inflammatory cytokines mRNA expression, and MAPKs phosphorylation were analyzed. We also measured the inflammatory gene expression in human pulmonary epithelial cells. Results In the study, we synthesized 30 curcumin analogs. The bioscreeening assay showed that most compounds inhibited LPS-induced production of TNF-α and IL-6. The active compounds, a17 , a18 , c9 and c26 , exhibited their anti-inflammatory activity in a dose-dependent manner and exhibited greater stability than curcumin in vitro . Furthermore, the active compound c26 dose-dependently inhibited ERK phosphorylation. In vivo , LPS significantly increased protein concentration and number of inflammatory cells in BALF, pulmonary edema, pathological changes of lung tissue, inflammatory cytokines in serum and BALF, macrophage infiltration, inflammatory gene expression, and MAPKs phosphorylation. However, pretreatment with c26 attenuated the LPS induced increase through ERK pathway in vivo. Meanwhile, compound c26 reduced the LPS-induced inflammatory gene expression in human pulmonary epithelial cells. Conclusions These results suggest that the novel curcumin analog c26 has remarkable protective effects on LPS-induced ALI in rat. These effects may be related to its ability to suppress production of inflammatory cytokines through ERK pathway. Compound c26 , with improved chemical stability and bioactivity, may have the potential to be further developed into an anti-inflammatory candidate for the prevention and treatment of ALI.

Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-α and TGF-β1) in murine model

Protective Effect of Curcumin on Endotoxin-Induced Acute Lung Injury in Rats

Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice

Curcumin Inhibits LPS-induced Inflammation in Rat Vascular Smooth Muscle Cells in Vitro Via ROS-relative TLR4-MAPK/NF-κB Pathways.

Thymol Mitigates Lipopolysaccharide-Induced Endometritis by Regulating the TLR4- and ROS-mediated NF-κB Signaling Pathways

Curcumin suppresses NLRP3 inflammasome activation and protects against LPS‐induced septic shock

The Anti-Inflammatory Effect of Curcumin in an Experimental Model of Sepsis is Mediated by Up-Regulation of Peroxisome Proliferator-Activated Receptor-Gamma

Curcumin ameliorates LPS/D-GalN induced acute liver injury by regulating TLR4/NF-кB/NLRP3 signaling pathway in vivo and in vitro

GW24-e1159 Curcumin Inhibits LPS-induced Inflammation in Rat Vascular Smooth Muscle Cells in Vitro Via ROS-relative TLR4-MAPK/NF-κB Pathways

The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration

Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis.

Curcumin attenuates lipopolysaccharide-induced renal inflammation.

Curcumin Elevates microRNA-183-5p via Cathepsin B-Mediated Phosphatidylinositol 3-Kinase/AKT Pathway to Strengthen Lipopolysaccharide-Stimulated Immune Function of Sepsis Mice

Curcumin alleviates LPS-induced inflammation and oxidative stress in mouse microglial BV2 cells by targeting miR-137-3p/NeuroD1

Curcumin Reduces LPS-induced Septic Acute Kidney Injury Through Suppression of Lncrna PVT1 in Mice.

Curcumin Alleviates DSS-induced Colitis Via Inhibiting NLRP3 Inflammsome Activation and IL-1β Production.

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury

Therapeutic potential of a triazole curcumin in inflammation: Decreased LPS-induced acute lung injury in mice by targeting MD2/TLR4

Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice

Curcumin Attenuates D-Galactosamine/Lipopolysaccharide–Induced Liver Injury and Mitochondrial Dysfunction in Mice

Curcumin Attenuates Lipopolysaccharide-Induced Neuroinflammation and Memory Deficiency by Inhibiting Microglia Activation in Mice Hippocampus